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Abstract  
 
Objectives To determine the association between mode of delivery (vaginal delivery [VD] vs 
cesarean section [CS]) and the rate of significant intraventricular hemorrhage (sIVH) in preterm 
infants.  
  
Methods A multi-centre retrospective cohort study, based on data collected from the Vermont 
Oxford Network database. Infants born between 23 and 31+6 weeks of gestational age between 
2001 and 2014 were identified. Exposure was the mode of birth (VD vs. CS). Primary outcome was 
development of sIVH. Data were analyzed using univariate and multivariate statistical methods.  
 
Results A total of 1575 infants were eligible. 902 infants were born by CS and 673 by VD. 
Univariable analysis showed that infants born vaginally were more likely to have sIVH (p<0.001), 
die before discharge (p<0.001), have a composite poor outcome (death, sIVH or PVL), need 
oxygen therapy at 36 weeks corrected gestation (p=0.010) and have a longer hospital stay 
(p=0.006). After adjusting for available confounders, multivariable analysis persistently showed that 
infants between 23-27 weeks born by CS were less likely to develop sIVH [OR 1.61 (1.01 to 2.58), 
p=0.049]. 
 
Conclusions sIVH is less common in very preterm infants (23-27 weeks of gestation) delivered by 
CS. However, neurodevelopmental risks associated with survival at this early age, as well as 
increased maternal morbidities must also be considered. 
 
 
 
  
  
Introduction 
 
Preterm infants are at high risk of poor neurodevelopmental outcomes and death. The biggest 
single cause of this, is the development of significant intraventricular hemorrhage (sIVH) following 
delivery [1]. SIVH, defined as grade 3 or 4, is predictive of major morbidity, which includes 
blindness, mental retardation, cerebral palsy and death. Various treatments have been tried to 
reduce the risk of IVH [1-6or to treat the infants following the development of sIVH, but none are 
routinely available or recommended [7]. 
 
The role of Cesarean Section (CS) as a protective measure against sIVH in very preterm infants 
has been proposed, yet the most optimal route of delivery continues to be hotly debated [8]. A 
recent Cochrane, systematic review and meta-analysis of interventional studies [9] found that not 
enough women have been recruited into trials of mode of birth at preterm gestations, and 
observational studies have been sparse. Observational studies demonstrated some benefit for CS 
in reducing neonatal mortality [10] but there is little to support its role in reducing neonatal 
morbidity as well, and specifically sIVH. Such evidence would be useful for informing discussions 
between pregnant women at risk of preterm birth and their caregivers, until evidence from 
randomized controlled trials becomes available. 
 
Our observational study aimed to determine the association between the mode of delivery (vaginal 
delivery [VD] vs. CS) and the rate of sIVH in very preterm infants in two large perinatal centers in 
Bristol, UK. 
 
Methods 
 
This is a retrospective observational study. We used the Vermont Oxford Network (VON) database 
(‘Nightingale’) to collect our data (https://public.vtoxford.org/). The VON Database was established 
in 1989, prospectively recording data on all infants born below 1500g or 32 weeks as well as 
infants meeting other eligibility requirements: even if the infant is not admitted to neonatal unit. 
  
Today, VON has evolved into a community of practice that includes nearly 1,000 centers around 
the globe that voluntarily submit data about the care and outcomes of high-risk newborn infants. 
While it’s main aim is that of benchmarking, its high-quality data standard is also ideal for novel 
research. Details of the background and structure of the database are available from the website 
https://public.vtoxford.org/about-us/. Data for VON are entered by individual units and collated by 
the network. Data were then extracted from this database using predetermined criteria for this 
work.  
 
All infants born in one of the two maternity units in Bristol, UK (Southmead Hospital, North Bristol 
NHS Trust and St Michael’s Hospital, University Hospitals Bristol) between 2001 and 2014 
(inclusive) were identified. Infants born between 23+0 and 31+6 weeks of gestational age were 
eligible (n=1,668). 93 (5.6%) infants had missing data on their IVH status, so were excluded, 
leaving 1575 infants for the analysis. Exposure was the mode of birth; defined as either VD or CS. 
The primary outcome was developing sIVH (defined as grade 3 or 4 [11), by 28 days of age, 
identified using any form of cranial imaging] and secondary outcomes were grade of IVH [11], 
periventricular leukomalacia (identified by day 28 using any form of cranial imaging), death prior to 
discharge, chronic lung disease (defined as oxygen requirement at 36 weeks corrected gestation) 
and length of stay in the level 3 neonatal unit (days) and a composite poor outcome (death, sIVH 
or PVL). Potential confounders were identified a-priori and categorized into two groups: 
 
• Antenatal (gender, antenatal steroids, maternal hypertension, multiple birth). 
• Intrapartum (birth weight, gestation, administration of magnesium sulphate, 
chorioamnionitis, early neonatal sepsis).  
 
All measures were derived from the definitions used by the Vermont Oxford Network 
[https://nightingale.vtoxford.org/help/AIT/WebHelp/index.htm#4658.htm] benchmarking 
database and further details are available on request. 
 
  
Initially the demographics and clinical characteristics of the cohorts were derived (Table 1). As data 
collection, and definitions, varied by year, not all measures (e.g. magnesium sulphate 
administration prior to delivery and delayed cord clamping) were recorded in all years. The 
univariable associations between vaginal delivery and CS were derived by comparing mode of 
delivery with the risk of sIVH and other secondary outcomes. For the regression models, a missing 
data technique was used to impute the missing covariates only, hence allowing all infants to be 
included in the adjusted regression models. Exposure and outcomes were not imputed. Details of 
the imputation process are shown in appendix 1. Logistic regression models were derived using 
sIVH as the dependent variable. Initially, an unadjusted analysis was performed, using a random 
effect multi-level model to allow for changes in CS rate over the 14-year period. A second model 
was derived after adjusting for the available confounders (above). The model was then repeated 
for the other, secondary outcomes. Finally, a linear regression model was derived to test the 
association between vaginal delivery and the length of stay.  
 
Five sensitivity analyses were performed; in the first, the analysis was repeated using only those 
infants with complete data (complete case analysis). We then repeated the analysis to test if any 
association was modified by gestational age (categorized as <28 weeks, or 28 weeks or greater), 
multiple birth or gender. Finally, we repeated the analysis using small for gestational age (SGA) 
(defined as a birth weight two of more SD below the gestational mean) rather than absolute 
birthweight as a potential confounder. Given the numbers of infants in the cohort (see Results) we 
have over 95% power to detect a decrease in severe IVH rates from 10% (vaginal birth) to 5% 
(caesarian section births), with an alpha of 0.05.  
 
Analysis was performed using STATA 14. Data is presented as n (%), median (IQR), mean (SD) or 
OR (95% CI) as appropriate. Ethical approval was obtained from the North Somerset and South 
Bristol Clinical Ethics Committee (ref: 11/sw/0209). 
 
Results 
 
  
A total of 1575 infants were eligible for the study. 902 (57.3%) infants were born by CS, and 673 
(42.7%) by VD. Infants born vaginally were more premature (26.6 vs 28.0 weeks), were more likely 
to be SGA (6.1% vs 0.6%), had smaller head circumference (24.8 vs 25.3 cm), and were more 
likely to have been exposed to chorioamnionitis (38.1% vs 22.9%) and develop perinatal sepsis 
(3.6% vs 1.4%). They were also less likely to have received antenatal steroids (86.7% vs 92.1%) 
or to have been exposed to maternal hypertension (2.4% vs 28.5%). Following birth, infants born 
by vaginally had significantly lower Apgar scores, were more likely to be intubated (81.7% vs 
71.2%), to have been given surfactant in the delivery room (73.3% vs 65.5%), and to have 
received more surfactant compared to infants delivered by CS (Table 1). 
 
In table 2, a univariable analysis was performed to assess association between mode of delivery 
and clinical outcomes. Results showed that infants born vaginally compared to those delivered by 
CS had a higher incidence of sIVH (16.2% vs 6.8%, p<0.001). They had a different profile of IVH 
grade (p<0.001), and were more likely to die before discharge (p<0.001), to have a composite poor 
outcome (death, sIVH or PVL), to need oxygen therapy at 36 weeks corrected gestation (p=0.010) 
and had a longer hospital stay (p=0.006). Risk of developing PVL was not associated by the mode 
of delivery. 
 
When the associations were tested in a regression model (table 3), the unadjusted results were 
compatible with the univariable analysis above. After adjusting for available confounders, results 
persistently showed that infants born vaginally had higher odds of sIVH (OR 1.61 (1.01 to 2.58), 
p=0.049). However, there were no association with the chance of death before discharge 
(p=0.687), PVL (p=0.420), death, sIVH or PVL (p=0.174), oxygen requirement at 36 weeks’ 
gestation (p=0.980), or total length of neonatal hospital stay (p=0.931).  
 
In the sensitivity analysis, first, a complete case analysis produced a less precise but compatible 
result to the main analysis (OR 3.51 (1.17 to 10.58)).  
 
  
After splitting the cohort by gestational age there was evidence that the association between 
vaginal delivery and sIVH remained in the extremely preterm (born before 28+0 weeks of gestation) 
infants (OR 2.05 (1.29 to 3.25)), but there was little evidence for this association in the more 
mature infants (OR 1.18 (0.51 to 2.72)), despite lack of evidence from interaction tests that the 
association was modified by gestational age (pinteraction=0.244) or multiple birth (pinteraction=0.864). 
There was, however, some evidence that gender modified the relationship (pinteraction=0.075), with 
male infants having a greater risk than female infants (OR 2.48 (1.22 to 5.06) vs 1.24 (0.74 to 
2.10)). Repeating the analysis controlling for IUGR (rather than birth weight) gave similar results to 
the main analysis (OR 1.61 (1.04 to 2.49)). 
 
Discussion 
 
Our analysis suggests that cesarean section was associated with a reduced incidence of sIVH for 
infants born at 23-27 weeks of gestation. This effect was still present even after adjusting for 
available confounding factors. We had limited statistical evidence from interaction tests that the 
effect differed by gestational age. Therefore, the attenuation of effect of CS on sIVH rates in infants 
born between 28-32 weeks in this study may simply be due to the smaller incidence, and hence 
precision, in those infants born at later gestations. In contrast, we were unable to find an 
association between the mode of delivery and other measures of neonatal outcome; mortality 
rates, periventricular leukomalacia, oxygen requirement at 36 weeks’ gestation or total length of 
neonatal hospital stay. Interestingly, although both genders had a raised risk for sIVH (albeit with 
wider confidence intervals), there was possible modification of the association by gender; male 
infants having greater risk of sIVH compared to female infants. Further work may help clarify if the 
association is truly different for male compared to female babies and why. 
 
Randomized controlled trials to assess the effect of mode of birth on perinatal outcomes in very 
preterm infants are limited and mostly incomplete in its data collection due to recruitment 
difficulties [9]. Most observational studies investigating mode of birth have assessed the 
association with mortality and report limited data on IVH outcomes [9,10,12]. Some work does 
  
however use IVH as the main outcome although the results are heterogeneous and this may be in 
part, secondary to differences in the populations (e.g. gestational ages).  A recent study 
investigating the impact of antenatal steroids on IVH risk, does report a potential benefit of the 
mode of delivery in the provisional analysis, although the association was not tested further in the 
adjusted regression analysis [13]. Also, another study by Dani et al [14] on 218 neonates, has 
found that infants with gestational age less than  28 weeks who were born vaginally compared to 
those born by CS, had a higher rate of grade 3 IVH (18% vs. 2%, p<0.0001) although other studies 
have not reported an association between the mode of birth and IVH [15-18].   
 
Results of these analyses must be interpreted with caution; this is a retrospective observational 
study, and therefore, some unknown biases and confounding variables are not accounted for. This 
work used data collected from VON, which is a well-established database used for both research 
and benchmarking and although it provides detailed definitions of the data-points, clinical 
judgement (e.g. if the IVH was a grade II or III) will still introduce some likely non-differential bias 
that could attenuate any association. Furthermore, some details of potential confounders were not 
available to use such as stage of labour on admission, spontaneous or induced preterm labor, 
planned or emergency CS, the presence of antepartum haemorrhage and the infant’s presenting 
part at time of delivery. However, it can be argued that infants with a breech presentation would 
have been more likely to be offered a CS [19,20], and if so, the effect seen in this work may have 
underestimated the benefits of CS in vertex presenting infants. The dataset has also changed over 
the years, and so we had missing data for some confounders (esp. antenatal magnesium sulphate) 
due to changes in data collection. However, this missing data is likely to be Missing Completely At 
Random (MCAR), so the missing data techniques used here would be appropriate. We have 
performed a complete case analysis which reported similar findings. Because of limitations in the 
data source, however, we were unable to measure maternal illness/morbidity (e.g. classical CS 
and its potential consequences) and did not have data on long term outcomes. Nevertheless, a 
reduction in sIVH rates of this magnitude is likely to have important long-term benefits [21]. 
 
  
SIVH is associated with motor and cognitive impairment in neonates as well as worse 
developmental outcomes in school and as adults, and according to the findings reported here may 
represent avoidable morbidity, at least to a degree. If the association seen here is true, the 
implications are important. IVH is now the single biggest cause of neurologic disability in the 
preterm population [22]. Its long-term effects can be devastating and treatment offered is very 
limited. Some evidence exists that rates can be reduced by delaying cord clamping [23], and 
antenatal delivery of vitamin K [24]. However, the hemorrhage can often cause significant damage 
to the surrounding white matter [11], and treatment once the condition has occurred is challenging 
[25]. However, prevention is more important. A reduction in IVH rates for preterm neonates would 
have important benefits for parents, family and society. Indeed, the observation of reduced IVH 
rates for infants delivered by CS between 23-28 weeks has serious implications for counselling 
parents regarding delivery options. At such discussions, it is vital not only to discuss with couples 
the likelihood of survival with each option but also the likelihood of neurodevelopmental disability, 
taking the gestational age into account. The likelihood of only 23-24% of neonates born at 24 
weeks being unimpaired may make some families think again regarding aggressive therapy and 
cesarean birth. At other gestations, the balance might be different, but parental values and wishes 
would remain an important determinant. 
 
Furthermore, the concept of planned CS for preterm birth implies that it is possible to diagnose 
preterm birth accurately and perform caesarean section prior to delivery. This is difficult and 
women thought to be in preterm labor may deliver weeks later, often at term. There is, therefore, a 
real possibility that a policy of CS may increase the number of babies born preterm if implemented 
too early.  It might be that a planned cesarean birth should only be discussed as an option with 
women who are in active preterm birth, with evidence of progressive cervical change, or as an 
alternative to induction of labor. This however should be discussed alongside the maternal risks of 
preterm CS, and the chance that it might be classical, aiming for informed joint decision making 
compliant with Montgomery principles [26]. 
 
 
  
Conclusion 
 
    This study has shown that infants between 23-27 weeks born by CS are less likely to develop 
sIVH compared to those born vaginal delivery, an association which persisted after adjustment for 
available confounders. Therefore, potentially suggesting that some of the morbidity seen in very 
preterm infants may be avoidable. However, we must be cautious when interpreting the results of 
this analysis and that any potential neonatal benefits should be balanced with the likely increase in 
maternal morbidities. We believe that results of this study would be useful to inform the urgent 
need for future work to provide a more robust evidence to confirm or refute these findings. 
However, in the meantime, this study offers valuable data to assist joint decision-making in the 
post-Montgomery era between obstetricians, neonatologists, and parents. 
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Table 1. Population characteristics in relation to mode of delivery 
Measure N Vaginal Birth CS P 
Gestational age (weeks) 1575 26.6 (2.3) 28.0 (2.0) <0.001 
Birth weight 1575 988 (306) 1000 (285) 0.453 
SGA (Weight 2 SD 
below the mean) 
1575 55 (6.1%) 4 (0.6%) <0.001 
Head circumference 936 24.8 (2.7) 25.3 (2.4) 0.002 
Multiple Birth 1575 194 (28.8%) 248 (27.5%) 0.561 
Antenatal Steroids 1567 581 (86.7%) 826 (92.1%) 0.001 
Chorioamnionitis 872 126 (38.1%) 124 (22.9%) <0.001 
Maternal Hypertension 872 8 (2.4%) 154 (28.5%) <0.001 
Male 1575 373 (55.4%) 454 (50.3%) 0.045 
Antenatal magnesium 300 37 (40.2%) 90 (43.3%) 0.622 
Early/Perinatal Sepsis 1575 24 (3.6%) 13 (1.4%) 0.006 
Apgar scores     
   1 minute 1575 5.8 (2.3) 6.3 (2.1) <0.001 
   5 minute 1574 7.8 (1.8) 8.3 (1.5) <0.001 
Intubation in DR 1575 550 (81.7%) 642 (71.2%) <0.001 
Surfactant in DR 1575 494 (73.3%) 591 (65.5%) 0.001 
Surfactant at any point 1575 574 (85.3%) 721 (80.0%) 0.006 
 
  Values are number (%) or mean (SD) as appropriate 
  DR: Delivery room 
 
  
  
Table 2. Associations between mode of birth and clinical outcomes. 
Outcome Measure N 
Vaginal Birth CS 
 
p 
Severe IVH 1575 109 (16.2%) 61 (6.8%) <0.001 
     
IVH grade 1575   <0.001 
   0  394 (58.5%) 711 (78.8%)  
   1  105 (15.6%) 81 (9.0%)  
   2  65 (9.7%) 49 (5.4%)  
   3  56 (8.3%) 32 (3.6%)  
   4  53 (7.9%) 29 (3.2%)  
Death before discharge  1575 118 (17.5%) 97 (10.8%) <0.001 
PVL 1573 32 (4.8%) 32 (3.6%) 0.229 
Death, sIVH or PVL 1575 196 (29.1%) 151 (16.7%) <0.001 
Length of stay     
   All infants 652  104 (67) 95 (56) 0.055 
   Excluding those that died 603 108 (66) 95 (53) 0.006 
O2 at 36 weeks 853 188 (55.5%) 239 (46.5%) 0.010 
 
  Values are number (%) or mean (SD) as appropriate 
 
 
  
  
  Table 3. Regression Models 
Outcome 
Measure 
N Unadjusted Adjusted* 
  OR (95% CI) P OR (95% CI) P 
Severe IVH 1575 2.67 (1.91 to 3.72) <0.001 1.61 (1.01 to 2.58) 0.049 
Death before 
discharge 
1575 1.76 (1.32 to 2.35) <0.001 0.92 (0.61 to 1.39) 0.687 
PVL 1573 1.36 (0.82 to 2.25) 0.228 1.28 (0.70 to 2.35) 0.420 
Death, sIVH or 
PVL 
1575 2.05 (1.61 to 2.61) <0.001 1.24 (0.91 to 1.70) 0.174 
Length of stay      
   All infants 652 9.23 (0.20 to 
18.66) 
0.055 -0.48 (-11.25 to 
10.30) 
0.931 
   Excluding 
those who died 
605 13.3 (3.8 to 22.8) 0.006 2.2 (-8.2 to 12.6) 0.683 
O2 at 36 weeks 853 1.44 (1.09 to 1.90) 0.011 1.01 (0.67 to 1.51) 0.980 
 
 
   Values are OR (95% confidence interval) or mean difference (95% confidence interval) as 
appropriate 
   *Adjusted for birth weight, gestation and gender, antenatal steroids, antenatal magnesium, 
chorioamnionitis, maternal hypertension, multiple birth, early neonatal sepsis 
   All models adjusted for year of birth using random-effects multi-level regression 
 
  
  
Appendix 1. Details of Multiple Imputation Methods 
 
All variables presented in the paper (including exposure and outcome variables) were included in 
the imputation model. Analysis was based on 80 imputed datasets. 
 
 
 
 
Imputation Variable n % 
Imputation 
Command 
Gestation 0 0.0% - 
IVH status 0 0.0% - 
Birth weight 0 0.0% - 
Gender 0 0.0% - 
Antenatal Steroids 8 0.5% logit 
Antenatal Magnesium 1,275 80.9% logit 
Chorioamnionitis 703 44.6% logit 
Maternal hypertension 703 44.6% logit 
Multiple birth 0 0.0% - 
Vaginal Delivery 0 0.0% - 
Oxygen requirement at 36 weeks 722 45.8% - 
PVL 2 0.1% logit 
Early Onset Sepsis 0 0.0% - 
Length of Stay 923 58.6% regress 
Death 0 0.0% - 
Apgar at 1 minute 13 0.8% ologit 
Apgar at 5 minutes 1 0.1% ologit 
Multiple Birth X Vaginal Delivery 0 0.0% - 
Gender X Vaginal Delivery 0 0.0% - 
Gestation X Vaginal Delivery 0 0.0% - 
